Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
321 hedge funds and large institutions have $2.32B invested in Avanos Medical in 2018 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 68 increasing their positions, 105 reducing their positions, and 69 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
17% more capital invested
Capital invested by funds: $1.98B → $2.32B (+$340M)
2% more call options, than puts
Call options by funds: $9.18M | Put options by funds: $9.03M
5% less funds holding
Funds holding: 338 → 321 (-17)
22% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 69
35% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 105
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$55.9M |
| 2 |
Lazard Asset Management
New York
|
+$20.7M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$15.3M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$15.3M |
| 5 |
CCM
Cloverdale Capital Management
Dallas,
Texas
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$54.3M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$29M |
| 3 |
HM
HealthCor Management
New York
|
-$28.9M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$22.2M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$18.7M |
AVNS Hedge Fund Activity: Q2 2018 in Review
321 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q2 2018, worth a combined $2.32B — up 17% from $1.98B a quarter earlier.
Sellers outnumbered buyers: 69 funds closed out of AVNS and 54 opened new positions — a net loss of 15 holders — while 105 trimmed existing stakes and 68 added.
The largest buyer was Victory Capital Management, adding an estimated $55.9M. The largest seller was Macquarie Group, cutting an estimated $54.3M.
- 321 institutional investors held Avanos Medical (AVNS) as of Q2 2018, down from 338 in Q1 2018.
- Funds reported $2.32B of Avanos Medical stock for Q2 2018, up 17% quarter-over-quarter.
- 54 funds opened new Avanos Medical positions in Q2 2018 and 69 closed out, a net change of -15 holders.
- The largest Avanos Medical buyer in Q2 2018 was Victory Capital Management, an estimated $55.9M added.
- The largest Avanos Medical seller in Q2 2018 was Macquarie Group, an estimated $54.3M sold.
Based on aggregated 13F filings for Q2 2018.